Truist Financial’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
WJWM
Truist Financial's IDXX Position: Q2 2026 in Review
Truist Financial reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $1.15M and leaving 13,894 shares worth $7.31M. The position accounts for 0.01% of the portfolio, ranked #749.
Truist Financial first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $47.3M in Q2 2021. 612 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Truist Financial held 13,894 shares of Idexx Laboratories worth $7.31M as of Q2 2026.
- Truist Financial sold 2,055 Idexx Laboratories shares in Q2 2026, an estimated $1.15M.
- Idexx Laboratories made up 0.01% of Truist Financial's portfolio in Q2 2026, its #749 holding.
- Truist Financial first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
- Truist Financial's Idexx Laboratories position peaked at $47.3M in Q2 2021.
- 612 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.